ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Clinical trial NCT06902272 · RECRUITING
Trial details
- NCT number
- NCT06902272
- Sponsor
- University of Miami
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2028-06-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.